drugset / Trial / NCT00667355
A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
NaSingle-groupOpen-labelTreatment
Summary
To evaluate efficacy, safety and pharmacokinetics of adalimumab in Japanese subjects with active ankylosing spondylitis
Timeline
- Start
- 2008-02
- Primary completion
- 2009-05
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adalimumab | Monoclonal antibody | 40 mg | Subcutaneous |
| Subject | Adalimumab | Monoclonal antibody | 80 mg | Subcutaneous |